Press Release 1998

Press Release 1998

Dr. Muhammed Majeed, President and founder of Sabinsa Corporation, announces that the company has been assigned a patent for Citrin® K. The US patent #5,783,603, dated July 21, 1998 is entitled "Potassium hydroxycitrate for the suppression of appetite and induction of weight loss."

Sabinsa offers Citrin® K in a standardized powdered extract. Citrin® K offers a wider array of applications for this popular weight loss ingredient, as an addition to beverages for example.

Hydroxycitric acid (RCA) was first made available in the US by Sabinsa Corporation in 1991 under the trademarked name Citrin®. Citrin®, the first all natural derivative of Garcinia cambogia ever introduced to the US and world markets, has been shown through independent laboratory analysis to contain the highest percentage of lactone-free hydroxycitric acid.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufacturers and supplies quality assured phytonutrients, standardized herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key staff.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.